Zoetis | ZTS - Gewinn Vor Steuern

Aktienkurs
115.67
Täglich Wechseln
-0.32 -0.28%
Monatlich
-8.05%
Jährlich
-29.05%
Q1 Prognose
112.20




Gewinn Vor Steuern Veränderung Datum
AbbVie USD 4.38B 1.92B 2025-09
Align Technology USD 176.6M 81.86M 2025-12
Bayer EUR -1.16B 735M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Coherus Biosciences USD -46.35M 90.86M 2025-12
Dentsply International USD -230M 77M 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Henry Schein USD 137M 16M 2025-09
Idexx Laboratories USD 306.98M 37.79M 2025-12
Illumina USD 220M 86M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
J&J USD 4.97B 2.53B 2025-12
Laboratory Of America USD 337M 32.3M 2025-09
Merck USD 6.74B 22M 2025-09
Neogen USD 28M 15.81M 2025-09
Pacira USD 9.52M 11.45M 2025-09
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 3.33B 290M 2025-09
Phibro Animal Health USD 38.62M 1.26M 2025-12
Quest Diagnostics USD 336M 57M 2025-09
Sanofi EUR -1.16B 5.5B 2025-12
Sanofi EUR -1.16B 6.23B 2025-12
Zoetis USD 887M 15M 2025-09